Skip to content

Clinical trials

Phase 3 Lupus Erythematosus, Systemic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 3 Country / region: Australia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20101
20112
20181
20191
20202
20211
20221
20233
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated5
Active, not recruiting4
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Novartis Pharmaceuticals3
EMD Serono Research & Development Institute, Inc.2
UCB Pharma2
AbbVie1
Biogen1
Bristol-Myers Squibb1
Human Genome Sciences Inc.1
Janssen Research & Development, LLC1
La Jolla Pharmaceutical Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic18
Autoimmune Diseases3
Connective Tissue Diseases2
Immune System Diseases2
Lupus Erythematosus, Cutaneous2
Lupus Erythematosus, Discoid2
Lupus Nephritis2
Nephritis1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.